A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
Clinical trial NCT06013995 · COMPLETED
Trial details
- NCT number
- NCT06013995
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-04-14
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.